SME Central
Home / SME Stocks / Sotac Pharmaceuticals

Sotac Pharmaceuticals: IPO, Share Price and Results Since Listing

Sotac Pharmaceuticals listed on NSE Emerge on 13 April 2023 after an IPO at INR 111 a share. On 9 November 2026 the shares closed at INR 130, 17.12% above the issue price. For H2 FY2026 it reported revenue of INR 60.06 crore (+35.30% on a year earlier) and a profit after tax of INR 3.32 crore.

Key Facts

IPO dates
29 March 2023 to 3 April 2023
Issue price
INR 111
Issue size
INR 33.30 crore
Subscription
1.07 times
Lead manager
Beeline Capital Advisors Private Limited
Listing day
opened at INR 115 (+3.60%), closed at INR 120.75 (+8.78%)
Listed on NSE Emerge
13 April 2023
Symbol
SOTAC
Latest close
INR 130 on 9 November 2026 (last traded day)
Against issue price
+17.12%
Lot size now
1,200 shares (INR 1,56,000 at the latest close)

Results Filed With NSE

Consolidated figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
H2 FY202660.06+35.30%3.323.01after listing26 May 2026
FY2026101.24+4.38%5.775.22after listing26 May 2026
H1 FY202637.01โ€“2.452.21after listing12 November 2025
H2 FY202544.39โ€“6.115.53after listing28 May 2025
FY202596.99โ€“8.037.26after listing28 May 2025

Promoter Holding

Promoter holding has moved from 72.85% on 20 April 2023 to 72.85% on 30 September 2026 (0 percentage points).

As ofPromotersPublic
30 September 202672.85%27.15%
31 March 202672.85%27.15%
30 September 202572.85%27.15%
31 March 202572.85%27.15%
30 September 202472.85%27.15%
31 March 202472.85%27.15%
30 September 202372.85%27.15%
20 April 202372.85%27.15%

Anchor Lock-ins

Lock-inEnds
30 days10 May 2023
90 days9 July 2023

Next Board Meeting

13 November 2026: Financial results

Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.